Defense Production Act

The Defense Production Act (DPA) was enacted in 1950 during the Korean War to give the executive branch authority to compel private industry to fulfil national defence needs. It allows the president to require companies to accept government contracts ahead of commercial orders, allocate materials and resources to defence priorities, and expand domestic industrial capacity. It has been invoked for everything from semiconductor supply chains to Covid-19 vaccine production, and remains the primary legal instrument through which Washington can direct private manufacturing without nationalising it.

Its absence from the 2026 Iran war is the legal and strategic anomaly analysts are tracking. Across 48 days of open conflict, the Trump administration has signed zero Iran-related executive orders, proclamations or memoranda. The DPA has not been invoked for munitions resupply, for fuel reserve management, or for any aspect of the Hormuz-driven supply crisis. At 40 days into the war, the nine most recent White House actions on file covered college sports, TSA pay, and a Greek Independence Day proclamation — none touching Iran, Hormuz, or defence production.

The contrast with prior US wartime practice is sharp. During the 2020-21 pandemic, DPA authorities were used to redirect manufacturing at speed. During the Ukraine conflict, the Biden administration invoked DPA to accelerate 155mm Shell production. The silence in 2026 suggests either that the administration is prosecuting the Iran campaign entirely through pre-authorised DoD channels and existing stockpiles, or that legal exposure around the War Powers Resolution is constraining any instrument that would formally name Iran as the adversary. Either reading matters for how long the campaign can be sustained without a congressional mandate.